Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSICfiledCriticalConsejo Superior de Investigaciones Cientificas CSIC
Priority to ES9700793ApriorityCriticalpatent/ES2136534B1/es
Publication of ES2136534A1publicationCriticalpatent/ES2136534A1/es
Application grantedgrantedCritical
Publication of ES2136534B1publicationCriticalpatent/ES2136534B1/es
Uso de la {w -1 secalina para la detección y seguimiento de la enfermedad celíaca, empleándola como antígeno en métodos inmunológicos. La {w -1 secalina es una proteína, extraída del centeno, que se purifica en etanol al 70% y permite desarrollar un sistema de inmunoblot para su aplicación.
ES9700793A1997-04-151997-04-15Uso de la w-1 secalina para la deteccion y seguimiento de la enfermedad celiaca.
Expired - Fee RelatedES2136534B1
(es)
ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ